Combination atezolizumab, bevacizumab, pemetrexed and carboplatin for metastatic EGFR mutated NSCLC after TKI failure.
Lam TC, Tsang KC, Choi HC, Lee VH, Lam KO, Chiang CL, So TH, Chan WW, Nyaw SF, Lim F, Lau JO, Chik J, Kong FM, Lee AW.
Lam TC, et al. Among authors: lam ko.
Lung Cancer. 2021 Sep;159:18-26. doi: 10.1016/j.lungcan.2021.07.004. Epub 2021 Jul 16.
Lung Cancer. 2021.
PMID: 34303276
Clinical Trial.